Dab2 inhibitors for the prevention and treatment of cystic fibrosis

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10864248
APP PUB NO 20170304392A1
SERIAL NO

15526392

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compositions and kits including an agent that inhibits the interaction between Disabled-2 and mutant CFTR proteins, optionally in combination with a CFTR corrector, CFTR potentiator, CAL inhibitor, mucolytic, anti-inflammatory agent or a combination thereof are provided as are methods for preventing or treating cystic fibrosis.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
TRUSTEES OF DARTMOUTH COLLEGE11 ROPE FERRY RD ROOM 6210 HANOVER NH 03755

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Madden, Dean R Hanover, US 12 27

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 15, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 15, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00